Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-179426
Filing Date
2025-08-13
Accepted
2025-08-13 07:16:39
Documents
78
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aura-20250630.htm   iXBRL 10-Q 2664571
2 EX-10.1 aura-ex10_1.htm EX-10.1 22924
3 EX-31.1 aura-ex31_1.htm EX-31.1 19158
4 EX-31.2 aura-ex31_2.htm EX-31.2 20210
5 EX-32.1 aura-ex32_1.htm EX-32.1 21933
  Complete submission text file 0001193125-25-179426.txt   9703748

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aura-20250630.xsd EX-101.SCH 1226768
80 EXTRACTED XBRL INSTANCE DOCUMENT aura-20250630_htm.xml XML 1659146
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40971 | Film No.: 251208979
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)